Aripiprazole can a viable choice for persistant suppression of symptoms in managing chronic tic disorders and Tourette's disorder through the life span: a case series
Yükleniyor...
Tarih
2016
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Kure Iletisim Grubu A S
Erişim Hakkı
info:eu-repo/semantics/openAccess
Özet
Tic disorders may cause impairment both by themselves and associated comorbidities. Medications for tic disorders are indicated when tics are moderate/ severe causing severe impairment and in presence of comorbid disorders responsive to medications. Duration of improvement is still not known as the literature lacks prospective studies with a long follow-up period. This case series aims to report management of tic disorders with aripiprazole in patients with different ages. Here, we describe 8 cases with complex motor tic disorder or Tourette's Disorder in which aripiprazole was used. The ages of patients were varied, from 9 to 57 years. Mean follow-up was 19.6 weeks. Mean dose of aripiprazole for pediatric patients was 15.4 mg/ day while it was 12.5 mg/ day for adult patients. All patients benefited from treatment with aripiprazole in the long term. Our results should be supported with controlled studies.
Açıklama
Anahtar Kelimeler
Aripiprazole, Tic, Tourette's Disorder
Kaynak
Klinik Psikofarmakoloji Bulteni-Bulletin Of Clinical Psychopharmacology
WoS Q Değeri
Q4
Scopus Q Değeri
N/A
Cilt
26
Sayı
2
